KR20090077014A - 3-벤질-2-메틸-2,3,3ａ,4,5,6,7,7ａ-옥타히드로벤조[ｄ]이속사졸-4-온의 염 - Google Patents

3-벤질-2-메틸-2,3,3ａ,4,5,6,7,7ａ-옥타히드로벤조[ｄ]이속사졸-4-온의 염 Download PDF

Info

Publication number
KR20090077014A
KR20090077014A KR1020097011287A KR20097011287A KR20090077014A KR 20090077014 A KR20090077014 A KR 20090077014A KR 1020097011287 A KR1020097011287 A KR 1020097011287A KR 20097011287 A KR20097011287 A KR 20097011287A KR 20090077014 A KR20090077014 A KR 20090077014A
Authority
KR
South Korea
Prior art keywords
oxalate
oxalate salt
formula
medicament
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020097011287A
Other languages
English (en)
Korean (ko)
Inventor
파비오 네기아니
라우라 디니
Original Assignee
아비오젠 파르마 에스피에이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아비오젠 파르마 에스피에이 filed Critical 아비오젠 파르마 에스피에이
Publication of KR20090077014A publication Critical patent/KR20090077014A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020097011287A 2006-11-02 2007-10-31 3-벤질-2-메틸-2,3,3ａ,4,5,6,7,7ａ-옥타히드로벤조[ｄ]이속사졸-4-온의 염 Withdrawn KR20090077014A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2006A002102 2006-11-02
IT002102A ITMI20062102A1 (it) 2006-11-02 2006-11-02 Nuovui sali di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidrobenzo-d-isossazol-4-one

Publications (1)

Publication Number Publication Date
KR20090077014A true KR20090077014A (ko) 2009-07-13

Family

ID=39145485

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020097011287A Withdrawn KR20090077014A (ko) 2006-11-02 2007-10-31 3-벤질-2-메틸-2,3,3ａ,4,5,6,7,7ａ-옥타히드로벤조[ｄ]이속사졸-4-온의 염
KR1020097011322A Withdrawn KR20090082452A (ko) 2006-11-02 2007-10-31 3-벤질-2-메틸-2,3,3ａ,4,5,6,7,7ａ-옥타히드로벤조[ｄ]이속사졸-4-온의 염

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020097011322A Withdrawn KR20090082452A (ko) 2006-11-02 2007-10-31 3-벤질-2-메틸-2,3,3ａ,4,5,6,7,7ａ-옥타히드로벤조[ｄ]이속사졸-4-온의 염

Country Status (20)

Country Link
US (2) US20100069451A1 (enExample)
EP (2) EP2094675B1 (enExample)
JP (2) JP2010509310A (enExample)
KR (2) KR20090077014A (enExample)
CN (2) CN101535281A (enExample)
AT (2) ATE502021T1 (enExample)
AU (2) AU2007315832A1 (enExample)
BR (2) BRPI0718391A2 (enExample)
CA (2) CA2667513A1 (enExample)
DE (2) DE602007013801D1 (enExample)
HR (2) HRP20090477A2 (enExample)
IL (2) IL198444A0 (enExample)
IT (1) ITMI20062102A1 (enExample)
MX (2) MX2009004293A (enExample)
NO (2) NO20092114L (enExample)
NZ (2) NZ577311A (enExample)
RS (2) RS20090389A (enExample)
RU (2) RU2009120667A (enExample)
WO (2) WO2008053326A1 (enExample)
ZA (2) ZA200903618B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20080768A1 (it) * 2008-04-24 2009-10-25 Abiogen Pharma Spa Procedimento per la preparazione di un composto in forma cristallina di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidro-benzo[d]isossazol-4-one
EP2112142A1 (en) * 2008-04-24 2009-10-28 Abiogen Pharma S.p.A. Process for preparing a crystalline form compound of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
EP2218721A1 (en) * 2009-02-11 2010-08-18 LEK Pharmaceuticals d.d. Novel salts of sitagliptin
WO2011010332A1 (en) * 2009-07-23 2011-01-27 Abiogen Pharma S.P.A. Process for preparing rel-(3r*,3as*,7as*)-3-benzyl-2-methyl-2,3, 3a,4,5,6,7,7a- octahydrobenzo[d]isoxazoi-4-one or a salt thereof
EP3250569B1 (en) * 2015-01-30 2019-01-09 Boehringer Ingelheim International GmbH Aldosterone synthase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4161595A (en) * 1978-10-02 1979-07-17 Bristol-Myers Company Levulinic acid salt
US4419358A (en) * 1981-11-12 1983-12-06 Mead Johnson & Company Isethionic acid salt of 9-cyclohexyl-2-propoxy-9H-purine-6-amine and compositions containing an effective bronchodilating concentration of it
GB2264299B (en) * 1992-02-19 1995-07-26 British Tech Group Iso-oxazolidine derivatives

Also Published As

Publication number Publication date
ZA200903618B (en) 2010-07-28
AU2007315832A1 (en) 2008-05-08
JP2010509309A (ja) 2010-03-25
NO20092114L (no) 2009-05-29
RS20090388A (sr) 2010-12-31
WO2008053325A1 (en) 2008-05-08
EP2094675B1 (en) 2011-04-06
ITMI20062102A1 (it) 2008-05-03
NO20092115L (no) 2009-05-29
MX2009004294A (es) 2009-05-08
CN101535282A (zh) 2009-09-16
CA2667513A1 (en) 2008-05-08
US20100069450A1 (en) 2010-03-18
NZ577311A (en) 2010-10-29
AU2007315833A1 (en) 2008-05-08
RU2009120667A (ru) 2010-12-10
BRPI0718392A2 (pt) 2013-11-26
CA2667515A1 (en) 2008-05-08
EP2094674B1 (en) 2011-03-16
RU2009120724A (ru) 2010-12-10
DE602007013278D1 (de) 2011-04-28
IL198444A0 (en) 2010-02-17
HRP20090470A2 (hr) 2009-11-30
HRP20090477A2 (hr) 2009-11-30
ATE502021T1 (de) 2011-04-15
US20100069451A1 (en) 2010-03-18
KR20090082452A (ko) 2009-07-30
EP2094675A1 (en) 2009-09-02
DE602007013801D1 (de) 2011-05-19
RS20090389A (sr) 2010-12-31
EP2094674A1 (en) 2009-09-02
NZ577978A (en) 2010-10-29
IL198443A0 (en) 2010-02-17
JP2010509310A (ja) 2010-03-25
ATE504578T1 (de) 2011-04-15
CN101535281A (zh) 2009-09-16
ZA200903810B (en) 2010-07-28
WO2008053326A1 (en) 2008-05-08
MX2009004293A (es) 2009-05-08
BRPI0718391A2 (pt) 2013-11-26

Similar Documents

Publication Publication Date Title
EP0497659B1 (fr) Dérivés d'aryl (ou hétéroaryl)-piperaz inyl-alkyl-azoles, leur préparation et leur application en tant que médicaments
JP5268902B2 (ja) ピロロピリミジノン誘導体の塩およびその製造方法
KR102442536B1 (ko) 리나글립틴 결정형 및 이의 제조방법
EP0506532A1 (fr) Nouveaux dérivés de l'indole, procédé de préparation et médicaments les contenant
OA12165A (fr) Dérivés aminés de dihydro-1,3,5-triazine et leurs applications en thérapeutique.
EP0446141B1 (fr) Nouveaux dérivés d'imidazo [1,2-C] quinazoline leur procédé de préparation et les compositions pharmaceutiques les renfermant
KR20090077014A (ko) 3-벤질-2-메틸-2,3,3ａ,4,5,6,7,7ａ-옥타히드로벤조[ｄ]이속사졸-4-온의 염
WO2001092261A1 (fr) Derives de 1,4-diazabicyclo [3.2.2]nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique
EP1861389B1 (fr) Sel besylate de la 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydro-pyrid-1-yl)ethyl) isoquinoleine, sa preparation et son utilisation en therapeutique
RU2330843C2 (ru) Амлодипина гентизат и способ его получения
JP6827124B2 (ja) （１ｒ，３ｓ）−３−（５−シアノ−４−フェニル−１，３−チアゾール−２−イルカルバモイル）シクロペンタンカルボン酸のアミン塩
CA2045849A1 (fr) Derives d'oxazolo pyridines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP2271343A1 (fr) Sels de quinoleines 2-substituees
JP2014501753A (ja) ３−クロロ−４［（２ｒ）−２−（４−クロロフェニル）−４−［（１ｒ）−１−（４−シアノフェニル）エチル］−１−ピペラジニル］−ベンゾニトリルの多形、前記多形を含む医薬組成物および使用方法、ならびにその調製方法
EP0322391A1 (en) New phenylalkylamine derivatives
JP2010518011A (ja) 化学化合物、医薬組成物および方法

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PC1203 Withdrawal of no request for examination

St.27 status event code: N-1-6-B10-B12-nap-PC1203

WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid
R18 Changes to party contact information recorded

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000